273 related articles for article (PubMed ID: 19337532)
1. Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes.
van de Laar FA
Vasc Health Risk Manag; 2008; 4(6):1189-95. PubMed ID: 19337532
[TBL] [Abstract][Full Text] [Related]
2. Who should benefit from the use of alpha-glucosidase inhibitors?
Godbout A; Chiasson JL
Curr Diab Rep; 2007 Oct; 7(5):333-9. PubMed ID: 18173965
[TBL] [Abstract][Full Text] [Related]
3. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.
Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; De Grauw WJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD005061. PubMed ID: 17054235
[TBL] [Abstract][Full Text] [Related]
4. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
5. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673
[TBL] [Abstract][Full Text] [Related]
6. Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
Hedrington MS; Davis SN
Expert Opin Pharmacother; 2019 Dec; 20(18):2229-2235. PubMed ID: 31593486
[No Abstract] [Full Text] [Related]
7. alpha-Glucosidase inhibitors.
Lebovitz HE
Endocrinol Metab Clin North Am; 1997 Sep; 26(3):539-51. PubMed ID: 9314014
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.
Joshi SR; Standl E; Tong N; Shah P; Kalra S; Rathod R
Expert Opin Pharmacother; 2015; 16(13):1959-81. PubMed ID: 26255950
[TBL] [Abstract][Full Text] [Related]
9. Can alpha-glucosidase inhibitors reduce the insulin dosage administered to patients with non-insulin-dependent diabetes mellitus?
Okada S; Ishii K; Hamada H; Tanokuchi S; Ichiki K; Ota Z
J Int Med Res; 1995; 23(6):487-91. PubMed ID: 8746617
[TBL] [Abstract][Full Text] [Related]
10. Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.
Rabasa-Lhoret R; Chiasson JL
Drugs Aging; 1998 Aug; 13(2):131-43. PubMed ID: 9739502
[TBL] [Abstract][Full Text] [Related]
11. Glucose supply and insulin demand dynamics of antidiabetic agents.
Monte SV; Schentag JJ; Adelman MH; Paladino JA
J Diabetes Sci Technol; 2010 Mar; 4(2):365-81. PubMed ID: 20307399
[TBL] [Abstract][Full Text] [Related]
12. Effect of an alpha-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients.
Saito N; Sakai H; Suzuki S; Sekihara H; Yajima Y
J Int Med Res; 1998; 26(5):219-32. PubMed ID: 9924706
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data.
Lin SD; Wang JS; Hsu SR; Sheu WH; Tu ST; Lee IT; Su SL; Lin SY; Wang SY; Hsieh MC
J Diabetes Complications; 2011; 25(5):332-8. PubMed ID: 21813293
[TBL] [Abstract][Full Text] [Related]
14. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
van de Laar FA; Lucassen PL; Akkermans RP; van de Lisdonk EH; Rutten GE; van Weel C
Diabetes Care; 2005 Jan; 28(1):154-63. PubMed ID: 15616251
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.
Johnston PS; Feig PU; Coniff RF; Krol A; Kelley DE; Mooradian AD
Diabetes Care; 1998 Mar; 21(3):416-22. PubMed ID: 9540025
[TBL] [Abstract][Full Text] [Related]
16. An importance of carbohydrate ingestion for the expression of the effect of alpha-glucosidase inhibitor in NIDDM.
Hara T; Nakamura J; Koh N; Sakakibara F; Takeuchi N; Hotta N
Diabetes Care; 1996 Jun; 19(6):642-7. PubMed ID: 8725865
[TBL] [Abstract][Full Text] [Related]
17. New pharmacological development (alpha glucosidase inhibitors, amylin analogues, GLP-1, thiozolidinediones, short acting insulin analogues).
Dharmalingam M; Kumar P
J Assoc Physicians India; 2001 Jan; 49 Spec No():46-9. PubMed ID: 11235605
[No Abstract] [Full Text] [Related]
18. Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Okada S; Ishii K; Tanokuchi S; Hamada H; Ichiki K; Ota Z
J Int Med Res; 1995; 23(4):279-83. PubMed ID: 7589771
[TBL] [Abstract][Full Text] [Related]
19. [Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors].
Blicklé JF; Andres E; Brogard JM
Rev Med Interne; 1999 Aug; 20 Suppl 3():379s-383s. PubMed ID: 10480189
[TBL] [Abstract][Full Text] [Related]
20. Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.
Johnston PS; Lebovitz HE; Coniff RF; Simonson DC; Raskin P; Munera CL
J Clin Endocrinol Metab; 1998 May; 83(5):1515-22. PubMed ID: 9589648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
